Thanks, Shelly. Today, I'll focus on three areas. First, our financial results, macro factors affecting performance and mitigating actions we're taking to offset pressures and risks. Second, the importance of supporting our innovations and demand drivers for the long-term in the face of near-term adversity, while taking actions to maintain maximum flexibility. And third, a review of key assumptions underlying our revised 2022 EPS guidance for $5 to $6, given the dynamic and challenging macro and consumer environments. Let's start with a review of macro factors that changed since our Q4 earnings call on February 23, and implications on our performance. Russia's invasions of -- invasion of Ukraine, the day after our earnings call, triggered international sanctions and significant spikes in the cost of petroleum, adding risk for derivative commodities, like foam and plastics. This has led to approximately $20 million of additional input cost pressures this year from commodities, fuel and inefficiencies caused by the uneven flow of chips. Consumer confidence has been impacted by the rapid inflation in gas and food prices, pressuring demand in March. This, coupled with Omicron affected demand in January resulted in a 3% year-over-year decline in Q1 demand. We are managing the business through changes in consumer behavior, challenges of inefficient supply flow and higher input costs, while navigating geopolitical events and low consumer confidence. As a result, we have lowered our expectations for 2022 demand growth and our EPS guidance. However, our differentiated strategy is more relevant than ever, and Sleep Number teams are highly engaged in our mission to improve lives. We remain committed to long-term shareholder value creation through our highly differentiated strategy. Now let's review first quarter net sales and financial details. Net sales in the first quarter of $527 million were down 7% versus the prior year on constrained electronic supply and lower-than-expected demand. While supply constraints in the quarter were largely as expected, the mix of Sleep Number smart beds ordered in the quarter, which we call demand, was significantly more profitable than the mix of smart beds delivered. This dynamic meaningfully impacted our Q1 financials as seen in our metrics. We delivered 108,000 smart beds in the quarter, down 5% versus the prior year with ARU of $4,905, which was down 2%. Contrast this with the ARU of our Q1 demand, which increased nearly 10% versus the prior year. That is a 12-point swing in these ARU measurements, most of which is in our undelivered backlog. During the quarter, we added approximately $50 million of net sales equivalents to our excess backlog, bringing that total to approximately $200 million. Q1 gross margin of 57.3% exceeded internal plans by more than 100 basis points as deliveries were level loaded throughout the quarter and benefited from pricing actions taken to date. Pressures causing the 530 basis point decline versus the prior year included the absorption of $140 million of annualized cost increases, lower overhead absorption on 5% fewer smart beds delivered and 25% fewer adjustable bases delivered in the quarter than the prior year due to current year chip supply constraints. Q1 operating expenses increased nearly 7%, reflecting the challenges of operating a business in this fast-changing environment. In the face of worsening macro challenges in March, we curtailed Q1 planned spend by about $10 million, while prioritizing near and long-term growth drivers. Despite these cost-cutting actions, the efficiency of our Q1 demand driving spend was negatively impacted by Omicron in January and by geopolitical events and low consumer confidence in March. Still, demand in the quarter exceeded deliveries due to constrained chip supply, leading to a 20% increase in backlog since December. Constrained deliveries of our most profitable sales resulted in EPS of $0.09 for the quarter compared with expectations for $0.30 to $0.40. We have responded to the changed macro environment by trimming our spending plans and being conservative with capital deployment as we continue to support our innovations, brand support and market expansion initiatives. Our commitment to drive long-term performance is evident in the 23% increase in R&D as our teams create game-changing innovations to be launched later this year and next. We expect these new sleep solutions to fuel future demand and improve future supply by using newer chip technology and fewer components. Our differentiators, plus efficiency driving digitization and an evolved logistic network lay the foundation for superior shareholder value creation in the years ahead. However, the current operating environment is dynamic and challenging. Our updated guidance reflects lower demand, additional cost pressures and service of our backlog as we continue to chase electronics supply. Let's review key assumptions supporting our updated 2022 EPS guidance. The $5 to $6 range is based on flat to low single-digit demand growth for the balance of the year. Sufficient chip supply to service a portion of our excess backlog within the year resulting in low double-digit net sales growth, and commodity and inefficient operating cost pressures arising from the uneven flow of chips that prevent us from level loading deliveries. This will be particularly challenging in Q2 when the delayed supply of chips due to the Shanghai lockdown will constrict weekly delivery in the first 7 to 8 weeks to about half the volume expected in the final weeks of the quarter. In total, we expect to deliver fewer smart beds in Q2 than Q1, but with a much stronger profit profile, which will be partly offset by the inefficient flow of deliveries. As a result, we now expect Q2 gross margin of 57% to 58% with improvements in the back half to 58% to 60%. We also expect to generate approximately $200 million of cash from operations in 2022 as changes in demand, backlog and working capital are less favorable than the prior year. Year-end debt leverage is expected to be approximately 3x EBITDA. We are actively managing all the levers in our control to balance near-term financial risks with our opportunities to create superior value long-term. Our approach is to preserve maximum flexibility to move quickly as business conditions change. The fundamentals of our strategy and our balance sheet are strong. We continue to drive to improve lives through proven quality sleep as the means to create superior shareholder value. Operator, please open the lines for questions.